| An oncolytic virus expressing IL15/IL15Rα combined with off-the-shelf EGFR-CAR NK cells targets glioblastoma R Ma, T Lu, Z Li, KY Teng, AG Mansour, M Yu, L Tian, B Xu, S Ma, ... Cancer research 81 (13), 3635-3648, 2021 | 105 | 2021 |
| The emerging field of oncolytic virus-based cancer immunotherapy R Ma, Z Li, EA Chiocca, MA Caligiuri, J Yu Trends in cancer 9 (2), 122-139, 2023 | 62 | 2023 |
| Co-expression of IL-7 improves NKG2D-based CAR T cell therapy on prostate cancer by enhancing the expansion and inhibiting the apoptosis and exhaustion C He, Y Zhou, Z Li, MA Farooq, I Ajmal, H Zhang, L Zhang, L Tao, J Yao, ... Cancers 12 (7), 1969, 2020 | 46 | 2020 |
| Procyanidin B2 Promotes Intestinal Injury Repair and Attenuates Colitis-Associated Tumorigenesis via Suppression of Oxidative Stress in Mice X Zhu, X Tian, M Yang, Y Yu, Y Zhou, Y Gao, L Zhang, Z Li, Y Xiao, ... Antioxidants & redox signaling 35 (2), 75-92, 2021 | 45 | 2021 |
| Specific targeting of glioblastoma with an oncolytic virus expressing a cetuximab-CCL5 fusion protein via innate and adaptive immunity L Tian, B Xu, Y Chen, Z Li, J Wang, J Zhang, R Ma, S Cao, W Hu, ... Nature cancer 3 (11), 1318-1335, 2022 | 28 | 2022 |
| Off-the-shelf CAR natural killer cells secreting IL-15 target spike in treating COVID-19 T Lu, R Ma, W Dong, KY Teng, DS Kollath, Z Li, J Yi, C Bustillos, S Ma, ... Nature Communications 13 (1), 2576, 2022 | 28 | 2022 |
| ILC1s control leukemia stem cell fate and limit development of AML Z Li, R Ma, S Ma, L Tian, T Lu, J Zhang, BL Mundy-Bosse, B Zhang, ... Nature immunology 23 (5), 718-730, 2022 | 28 | 2022 |
| Knockout of P2Y12 aggravates experimental autoimmune encephalomyelitis in mice via increasing of IL-23 production and Th17 cell differentiation by dendritic cells J Zhang, Z Li, X Hu, Q Su, C He, J Liu, H Ren, M Qian, J Liu, S Cui, ... Brain, Behavior, and Immunity 62, 245-255, 2017 | 25 | 2017 |
| REGγ drives Lgr5+ stem cells to potentiate radiation induced intestinal regeneration X Zhu, M Yang, Z Lin, SK Mael, Y Li, L Zhang, Y Kong, Y Zhang, Y Ren, ... Science China Life Sciences 65 (8), 1608-1623, 2022 | 17 | 2022 |
| Hijacking TYRO3 from tumor cells via trogocytosis enhances NK-cell effector functions and proliferation T Lu, R Ma, Z Li, AG Mansour, KY Teng, L Chen, J Zhang, T Barr, ... Cancer immunology research 9 (10), 1229-1241, 2021 | 14 | 2021 |
| Cbl-B is upregulated and plays a negative role in activated human NK cells T Lu, L Chen, AG Mansour, MJ Yu, N Brooks, KY Teng, Z Li, J Zhang, ... The Journal of Immunology 206 (4), 677-685, 2021 | 12 | 2021 |
| Immethridine, histamine H3-receptor (H3R) agonist, alleviated experimental autoimmune encephalomyelitis via inhibiting the function of dendritic cells Y Shi, Z Li, R Chen, J Zhang, X Hu, C He, Q Su, H Ma, H Ren, M Qian, ... Oncotarget 8 (43), 75038, 2017 | 11 | 2017 |
| P2Y6 Deficiency Enhances Dendritic Cell–Mediated Th1/Th17 Differentiation and Aggravates Experimental Autoimmune Encephalomyelitis Z Li, C He, J Zhang, H Zhang, H Wei, S Wu, W Jiang The Journal of Immunology 205 (2), 387-397, 2020 | 9 | 2020 |
| An XBP1s–PIM-2 positive feedback loop controls IL-15–mediated survival of natural killer cells S Ma, J Han, Z Li, S Xiao, J Zhang, J Yan, T Tang, T Barr, AS Kraft, ... Science immunology 8 (81), eabn7993, 2023 | 8 | 2023 |
| Purinergic receptor P2Y6 is a negative regulator of NK cell maturation and function Z Li, Y Gao, C He, H Wei, J Zhang, H Zhang, L Hu, W Jiang The Journal of Immunology 207 (6), 1555-1565, 2021 | 8 | 2021 |
| B7H6 serves as a negative prognostic marker and an immune modulator in human pancreatic cancer Z Zhu, KY Teng, J Zhou, Y Xu, L Zhang, H Zhao, X Zhang, L Tian, Z Li, ... Frontiers in Oncology 12, 814312, 2022 | 7 | 2022 |
| Human ILC1s target leukemia stem cells and control development of AML M Caligiuri, Z Li, R Ma, H Tang, J Zhang, G Marcucci, J Yu Research Square, 2023 | 3 | 2023 |
| Therapeutic application of human type 2 innate lymphoid cells via induction of granzyme B-mediated tumor cell death Z Li, R Ma, H Tang, J Guo, Z Shah, J Zhang, N Liu, S Cao, G Marcucci, ... Cell 187 (3), 624-641. e23, 2024 | 2 | 2024 |
| Abstract LB211: Tumor-reactive and anti-PD-L1 co-stimulated killer cells (TRACK-NK) for immunotherapy of non-small cell lung cancer T Lu, AG Mansour, R Ma, C Bustillos, Z Li, S Ma, Z Li, H Chen, KY Teng, ... Cancer Research 82 (12_Supplement), LB211-LB211, 2022 | 2 | 2022 |
| Preclinical Evaluation of Off-The-Shelf PD-L1+ Human Natural Killer Cells Secreting IL15 to Treat Non–Small Cell Lung Cancer T Lu, R Ma, AG Mansour, C Bustillos, Z Li, Z Li, S Ma, KY Teng, H Chen, ... Cancer Immunology Research, OF1-OF13, 2024 | | 2024 |
Rui MaVerified email at coh.org
